Buccal Misoprostol and Intravenous Tranexamic Acid During Emergent Cesarean Delivery
Status:
Unknown status
Trial end date:
2021-01-31
Target enrollment:
Participant gender:
Summary
Purpose to evaluate the effects of buccal misoprostol with or without intravenous tranexamic
acid (TA) in comparison with placebo on reducing post-partum hemorrhage in pregnant women
undergoing emergent cesarean section